The Bellmunt Risk Score can provide prognostic information on survival among patients with metastatic castration-resistant prostate cancer, new data suggest.

A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...

Using de-identified data from the National Cancer Institute, researchers followed 205 patients—average age, 61 years—with prostate cancer and preexisting depression. Patients with both conditions had ...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

February 26, 2007 — A blood test for C-reactive protein (CRP), which is readily available and already used to assess the risk of cardiovascular disease, could be useful in predicting prognosis for men ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...

Former US president Joe Biden could have fewer than five years left to live because his prostate cancer is aggressive, has spread and was caught late, data suggests. The 82-year-old's diagnosis was ...

PHILADELPHIA -- Former President Joe Biden is being treated for prostate cancer, one of the most common cancers among men. Biden's cancer is an aggressive form of the disease, and has spread to his ...

CINCINNATI (WKRC) — Former President Joe Biden was diagnosed with an aggressive form of prostate cancer that has spread to the bone, but doctors remained optimistic about his prognosis. Dr. Mark ...